Tenderwize
Back to tender search

Medicinal products with Guselkumab

AOK Sachsen - Anhalt·Magdeburg, Germany·Deadline May 30, 2028 · 557 days left·Open·Supplies
Original notice title

Germany – Pharmaceutical products – Arzneimittel mit dem Wirkstoff Guselkumab (ATC: L04AC16)

61/100

Opportunity Score

Needs reviewMedium complexity
SuppliesOpen
Why this score?

Opportunity

61 / 100

Complexity

58 / 100

Risk factors

No value, volume, purchasing commitment, or guaranteed demand is disclosed.

The agreement may end under its contractual provisions if AOK Sachsen-Anhalt later awards an exclusive contract for the...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Tender facts

Contracting authority
AOK Sachsen - Anhalt
Country
Germany
CPV
33600000 - Pharmaceutical products
Deadline
May 30, 2028

Overview

Moderate opportunity

Key Facts

  • Supplies contract
  • 1 lot
  • Duration 2 YEAR
  • Supply of finished medicinal products containing guselkumab (ATC L04AC16).
  • Conclusion or accession to non-exclusive rebate agreements under §130a(8) SGB V.
Show full summary

Open-house model for non-exclusive rebate agreements under §130a(8) SGB V covering finished medicinal products containing guselkumab (ATC L04AC16). Any pharmaceutical company or consortium meeting the participation requirements may conclude an agreement on identical conditions, without exclusivity or individual negotiations. The notice states that this is not a public contract under German procurement law. Procurement documents were not substantively analyzed; only the extracted TED XML notice is available.

Risks

No value, volume, purchasing commitment, or guaranteed demand is disclosed.

The agreement may end under its contractual provisions if AOK Sachsen-Anhalt later awards an exclusive contract for the...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • The same contractual conditions and access procedure apply to all participants.

Administrative

  • The interested pharmaceutical company must request the participation documents and the relevant agreement from the stated contact address.
  • Requested participation documents must be completed in full and signed.

Buyer

Location

Magdeburg, DEU

Buyer profile

Open profile

Identifier

DE258393558

Activity

Health

Lots (1)

LOT-0001

Guselkumab Medicinal Products

Non-exclusive rebate agreement for finished medicinal products containing guselkumab (ATC L04AC16) under an open-house model. Eligible pharmaceutical companies may join or conclude an agreement at any time on identical conditions. The contract may begin from 1 August 2026, lasts for a maximum of 24 months, and ends on 31 July 2028 irrespective of its start date. Individual negotiations are not conducted.

SuppliesEU fundedElectronic submission

Location

DEE03, Germany

Duration

2 YEAR

Category

Pharmaceutical products

Deadline

Deadline May 30, 2028

Procurement Details

Publication date
11 Jun 2026
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
405849-2026

Documents (1)

Similar tenders

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy